Back in December 2019, there was an article written around the findings of the US-China Economic and Security Review Commission that focused on China’s efforts to become the world’s largest producer of pharmaceutical products. It was not given much play time.

Rosemary Gibson, an author and adviser on health care issues at the Hastings Center, was the co-author of a book: “China Rx: Exposing the Risks of America’s Dependence on China for Medicine.”

In that book, she said three interesting things:

“Medicines can be used as a weapon of war against the United States.”

“Supplies can be withheld. Medicines can be made with lethal contaminants or sold without any real medicine in them, rendering them ineffective.”

“If China shut the door on exports of medicines and their key ingredients and raw material, US hospitals and military hospitals and clinics would case to function within months, if not days.”

Now, the United States finds itself in exactly the vulnerable position that both of these writings suggested might happen.

Continue reading →